| 000 | 01786 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516145251.0 | ||
| 264 | 0 | _c20131113 | |
| 008 | 201311s 0 0 eng d | ||
| 022 | _a1365-2133 | ||
| 024 | 7 |
_a10.1111/bjd.12144 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBacchetti, T | |
| 245 | 0 | 0 |
_aOxidative stress and psoriasis: the effect of antitumour necrosis factor-α inhibitor treatment. _h[electronic resource] |
| 260 |
_bThe British journal of dermatology _cMay 2013 |
||
| 300 |
_a984-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAryldialkylphosphatase _xmetabolism |
| 650 | 0 | 4 |
_aBiomarkers _xmetabolism |
| 650 | 0 | 4 |
_aC-Reactive Protein _xmetabolism |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xtherapeutic use |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aLipid Peroxidation _xdrug effects |
| 650 | 0 | 4 |
_aLipids _xblood |
| 650 | 0 | 4 |
_aLipoprotein(a) _xblood |
| 650 | 0 | 4 |
_aLipoproteins, HDL _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOxidation-Reduction _xdrug effects |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 |
_aPsoriasis _xblood |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xtherapeutic use |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aCampanati, A | |
| 700 | 1 | _aFerretti, G | |
| 700 | 1 | _aSimonetti, O | |
| 700 | 1 | _aLiberati, G | |
| 700 | 1 | _aOffidani, A M | |
| 773 | 0 |
_tThe British journal of dermatology _gvol. 168 _gno. 5 _gp. 984-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bjd.12144 _zAvailable from publisher's website |
| 999 |
_c22696694 _d22696694 |
||